Sinphar Pharmaceutical Co.,Ltd. (1734.TW) TAI

32.00

+0.15(+0.47%)

Updated at November 07 02:36PM

Currency In TWD

Valuation

Market Cap5.38B
Enterprise Value6.21B
P/E Ratio18.5
PEG Ratio15.63
Price/Sales Ratio1.89
Price/Book Ratio1.79
Enterprise/Revenue2.13
Enterprise/EBITDA10.81

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.11

Management Effectiveness

Return On Assets0.05
Return On Equity0.1

Income Statement

Revenue3.15B
Revenue/Share17.99
Gross Profit1.24B
EBITDA601.24M
Net Income304.71M
Diluted EPS1.68

Balance Sheet

Total Cash1.02B
Total Cash/Share5.71
Total Debt1.67B
Total Debt/Equity0.52
Current Ratio2.07
Book Value Per Share19.31

Price History

52-Week Change9.63
52-Week High32.6
52-Week Low25.95
Moving Average 50 Days31.11
Moving Average 200 Days30.51

Statistics

Average Volume226,898
Shares Outstanding190.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.95
Trailing Annual Dividend Yield2.98
Payout Ratio0.54
Last Split Factor21:20
Last Split DateSeptember 02, 2025